Drug Discovery World

JUNE 29, 2023

It’s been another busy month for senior appointments in the drug discovery sector. David Favre, Chief Development Officer, SpliceBio Dr Favre brings more than 25 years of experience in gene therapy, immunology and drug development throughout academia and the biopharma industry.

Drugs 52

Drugs Gene Therapy Development Clinical Trials 52

The Pharma Data

DECEMBER 17, 2020

Cadavid will be responsible for the strategy, direction and execution of the company’s clinical development programs. Prior to Fulcrum, Cadavid held several leadership positions at Biogen, including Senior Medical Director of the multiple sclerosis clinical development group. based Rinri Therapeutics.

Development 52

Development Gene Therapy Engineer Life Science 52

Drug Discovery World

JUNE 16, 2023

This experience also involves technology transfers, for therapies across the clinical development stages and for developers based across global regions, from the US, through Europe and to China. This experience has resulted in very low batch failure rates, which has a considerable reduction in the cost of production.

Manufacturing 52

Manufacturing In-Vivo Production Compliance 52

Drug Discovery World

JUNE 15, 2023

However, we need to avoid unnecessary delays in clinical development, and interactions between EU countries and with US regulators need to be homogenised if we want to interact with EU and US regulators.” BioSenic’s had 44 centres open in Europe for the latest Phase IIb clinical trial for difficult tibia fractures, which is just finishing.

Regulation 52

Regulation Production Development Medicine 52

The Pharma Data

NOVEMBER 3, 2020

According to the FDA, the purpose of Fast Track designation is to get important new drugs to patients earlier by facilitating the development, and expediting the review, of drugs to treat serious conditions and fill an unmet medical need. LogicBio is also developing a Next Generation Capsid platform for use in gene editing and gene therapies.

Clinical Trials 52

Clinical Trials Clinical Trials Gene Editing Genome 52

Drug Discovery World

APRIL 29, 2024

Hall has been with the company for more than 16 years, including as Chief Commercial Officer, and was previously Head of Business Development in Europe for Cyprotex. Bironneau brings over two decades of commercial leadership experience, including as Vice President, Global Sales & Business Development at Axplora and Novasep.

Drugs 52

Drugs Sales Gene Therapy Life Science 52

The Pharma Data

NOVEMBER 5, 2020

Velders is presently chairman of HollandBIO, the association of Dutch biotech companies, and provides years of experience, specifically in the cell and gene therapy areas. Before joining Kite, he was chief scientific officer at Dutch AM-Pharma, Business Unit Manager at TNO Biosciences and chief executive officer at SomantiX.

Genome 40

Genome Genomics Medicine Life Science 40

The Pharma Data

OCTOBER 15, 2020

The committee is tasked with supporting BeyondSpring’s business development activities related to its lead asset, Plinabulin, and other pipeline assets. Mukul Agarwal, former vice president of Corporate Development, at Forty Seven, Inc., Mukul Agarwal, former vice president of Corporate Development, at Forty Seven, Inc.,

In-Vivo 52

In-Vivo Business Development Manufacturing Development 52

Drug Discovery World

NOVEMBER 13, 2023

Yuchih Lin, Doctor, Sino Biological Europe, on: ‘Accelerating drug discovery using advanced antibody development platforms’. Ellen Hilgenberg, PhD, Senior Business Development Manager, Business Development, ProBioGen, on: ‘DirectedLuck for bispecifics – a transposase system streamlines cell line development’.

Protein 59

Protein Antibody Engineer Scientist 59

XTalks

AUGUST 2, 2023

They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities. Meanwhile, BioMarin’s gene therapy Roctavian is approved by the FDA for the treatment of hemophilia A.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

Pharmaceutical Technology

JANUARY 26, 2023

Cell and gene therapies are predicted to be the future of medical treatment by providing the body with the means to repair itself and recover from a range of serious conditions and severe diseases. Often, cell and gene therapies are spoken of as miracle treatments, yet this progress has hardly occurred overnight.

Gene Therapy 130

Gene Therapy Gene Medicine Manufacturing 130